Georgette Thumshirn

Title: Georgette Thumshirn: Innovator in Integrin Inhibitors

Introduction

Georgette Thumshirn is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of integrin inhibitors. Her innovative work has the potential to impact various medical conditions.

Latest Patents

Thumshirn holds a patent for Isoquinoline derivatives. This patent describes compounds of the general formula (I), where X, Y, Z, R, and n are defined in the patent claim. These derivatives are recognized for their role as integrin inhibitors and can be utilized in combating thromboses, cardiac infarction, coronary heart diseases, arteriosclerosis, inflammation, tumors, osteoporosis, infections, and restenosis after angioplasty. The physiologically acceptable salts or solvates of these compounds further enhance their therapeutic applications.

Career Highlights

Georgette Thumshirn is associated with Merck Patent GmbH, where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and improving patient outcomes through her inventions.

Collaborations

Thumshirn collaborates with notable colleagues, including Matthias Wiesner and Simon Lawrence Goodman. Their combined expertise contributes to the success of their projects and the advancement of medical science.

Conclusion

Georgette Thumshirn is a trailblazer in the field of integrin inhibitors, with her patent on Isoquinoline derivatives showcasing her innovative spirit. Her contributions to Merck Patent GmbH and collaborations with esteemed colleagues highlight her dedication to improving healthcare through scientific advancements.